Evidence map›Paper›PMID 26725955›Full record

ArticleScientific reports2016

Detachment of surface membrane invagination systems by cationic amphiphilic drugs.

Sangar Osman, Kirk A Taylor, Natalie Allcock, Richard D Rainbow, Martyn P Mahaut-Smith

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. A Correlative SICM-OPM Platform for Surface and Volumetric Imaging in Live Cells.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Article
  4. Antiviral activity of cationic amphiphilic drugs.Expert review of anti-infective therapy · 2017
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sangar OsmanDepartment of Molecular and Cell Biology, University of Leicester, Leicester, UK, LE1 9HN.
Kirk A TaylorDepartment of Molecular and Cell Biology, University of Leicester, Leicester, UK, LE1 9HN.
Natalie AllcockCentre for Core Biotechnology Services, University of Leicester, Leicester, UK, LE1 9HN.
Richard D RainbowDepartment of Cardiovascular Sciences, University of Leicester, Leicester, UK, LE1 9HN.
Martyn P Mahaut-SmithDepartment of Molecular and Cell Biology, University of Leicester, Leicester, UK, LE1 9HN.
University of Leicester · GB

Funding

Medical Research Council G0301031
6 · The paper itself

Abstract

Several cell types develop extensive plasma membrane invaginations to serve a specific physiological function. For example, the megakaryocyte demarcation membrane system (DMS) provides a membrane reserve for platelet production and muscle transverse (T) tubules facilitate excitation:contraction coupling. Using impermeant fluorescent indicators, capacitance measurements and electron microscopy, we show that multiple cationic amphiphilic drugs (CADs) cause complete separation of the DMS from the surface membrane in rat megakaryocytes. This includes the calmodulin inhibitor W-7, the phospholipase-C inhibitor U73122, and anti-psychotic phenothiazines. CADs also caused loss of T tubules in rat cardiac ventricular myocytes and the open canalicular system of human platelets. Anionic amphiphiles, U73343 (a less electrophilic U73122 analogue) and a range of kinase inhibitors were without effect on the DMS. CADs are known to accumulate in the inner leaflet of the cell membrane where they bind to anionic lipids, especially PI(4,5)P2. We therefore propose that surface detachment of membrane invaginations results from an ability of CADs to interfere with PI(4,5)P2 interactions with cytoskeletal or BAR domain proteins. This establishes a detubulating action of a large class of pharmaceutical compounds.

Indexed as

AnimalsCells, CulturedCell Surface ExtensionsDrug Evaluation, PreclinicalEstrenesMaleMegakaryocytesMyocytes, CardiacPhenothiazinesPyrrolidinonesRats, WistarSulfonamides1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dioneEstrenesPhenothiazinesPyrrolidinonesSulfonamidesU 73343W 7

Identifiers

PMID26725955
PMCPMC4698757
OpenAlexW2229276467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.